Cleared Traditional

K080428 - ATTAIN COMMAND 6250 LEFT HEART DELIVERY...

K080428 is the FDA 510(k) clearance for ATTAIN COMMAND 6250 LEFT HEART DELIVERY... by Medtronic, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 294-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2008
Decision
294d
Days
Class 2
Risk

K080428 is an FDA 510(k) clearance for the ATTAIN COMMAND 6250 LEFT HEART DELIVERY SYSTEMS AND ATTAIN COMMAND 6250 GUIDE.... Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on December 9, 2008 after a review of 294 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtronic, Inc. devices

Submission Details

510(k) Number K080428 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 2008
Decision Date December 09, 2008
Days to Decision 294 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
169d slower than avg
Panel avg: 125d · This submission: 294d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 552
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K080428.
CONQUEST PTA BALLOON DILATATION CATHETER
K083657 · C.R. Bard, Inc. · Dec 2008
CPS AIM SL SLITTABLE INNER CATHETER
K082932 · St Jude Medical · Dec 2008
CHAPERON GUIDING CATHETER
K082385 · MicroVention, Inc. · Dec 2008
MODIFICATION TO: ATTAIN PREVAIL 6228CTH80 STEERABLE CATHETER SET
K082670 · Medtronic, Inc. · Dec 2008
HEADWAY 17 MICROCATHETER
K083343 · MicroVention, Inc. · Dec 2008
NEURON SELECT CATHETER SIZE 070
K083125 · Penumbra, Inc. · Nov 2008